Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis
Medical Journal of South Punjab · 2025
DOI: 10.61581/mjsp.v5i01.375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of South Punjab, 2025. Verfasst von Saima Shahid und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective: The study aims to compare the efficacy and safety of meglumine antimoniate and miltefosine in the treatment of cutaneous leishmaniasis in Pakistan. Methodology: This randomized-controlled trial was conducted at the Dermatology Departments of Pak Emirates Military Hospital Rawalpindi, Pakistan, from 10 July 2024 to 9 January 2025. Efficacy was graded on Day 28 as excellent (91-100% improvement), good (75-90%), fair (50-74%), or poor (
Zitieren
APA
Shahid, S., & Akhter, A. (2025). Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis. Medical Journal of South Punjab. https://doi.org/10.61581/mjsp.v5i01.375
Vancouver
Shahid S, Akhter A. Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis. Medical Journal of South Punjab. 2025. doi:10.61581/mjsp.v5i01.375
BibTeX
@article{Shahid2025,
author = {Shahid, Saima and Akhter, Aisha},
title = {Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis},
journal = {Medical Journal of South Punjab},
year = {2025},
doi = {10.61581/mjsp.v5i01.375}
}
EUVIMED